Page last updated: 2024-11-03

prazosin and Nocturnal Wandering

prazosin has been researched along with Nocturnal Wandering in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research Excerpts

ExcerptRelevanceReference
"DNB ranged from vocalizations, somnambulism to combative behaviors that injured bed partners."1.40Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors. ( Germain, A; Kwon, HP; Mysliwiec, V; O'Reilly, B; Polchinski, J; Roth, BJ, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mysliwiec, V1
O'Reilly, B1
Polchinski, J1
Kwon, HP1
Germain, A1
Roth, BJ1

Other Studies

1 other study available for prazosin and Nocturnal Wandering

ArticleYear
Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014, Oct-15, Volume: 10, Issue:10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Continuous Positive Airway Pressure; Dreams; Humans;

2014